These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A model for quantitative measurement of sulfur mustard skin lesions in the rabbit ear. Zlotogorski A; Goldenhersh M; Shafran A Toxicology; 1997 Jun; 120(2):105-10. PubMed ID: 9184197 [TBL] [Abstract][Full Text] [Related]
5. Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Dachir S; Fishbeine E; Meshulam Y; Sahar R; Amir A; Kadar T Hum Exp Toxicol; 2002 Apr; 21(4):197-203. PubMed ID: 12099621 [TBL] [Abstract][Full Text] [Related]
6. Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard. Casbohm SL; Rogers JV; Stonerock MK; Martin JL; Ricketts-Kaminsky KM; Babin MC; Casillas RP; Sabourin CL Toxicology; 2004 Nov; 204(2-3):229-39. PubMed ID: 15388249 [TBL] [Abstract][Full Text] [Related]
7. Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods. Dachir S; Cohen M; Fishbeine E; Sahar R; Brandies R; Horwitz V; Kadar T Skin Res Technol; 2010 Feb; 16(1):114-24. PubMed ID: 20384890 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous protease activity in the mouse ear vesicant model. Powers JC; Kam CM; Ricketts KM; Casillas RP J Appl Toxicol; 2000 Dec; 20 Suppl 1():S177-82. PubMed ID: 11428632 [TBL] [Abstract][Full Text] [Related]
10. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. Yourick JJ; Dawson JS; Mitcheltree LW J Appl Toxicol; 1995; 15(2):133-8. PubMed ID: 7782559 [TBL] [Abstract][Full Text] [Related]
11. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. Smith KJ; Casillas R; Graham J; Skelton HG; Stemler F; Hackley BE J Dermatol Sci; 1997 Feb; 14(2):126-35. PubMed ID: 9039976 [TBL] [Abstract][Full Text] [Related]
13. Novel endogenous inhibitor of sulfur mustard-stimulated protease in cultured human epidermal keratinocytes: possible application in vesicant intervention. Chakrabarti AK; Ray P J Appl Toxicol; 2000 Dec; 20 Suppl 1():S59-61. PubMed ID: 11428644 [TBL] [Abstract][Full Text] [Related]
14. Use of the mouse ear vesicant model to evaluate the effectiveness of ebselen as a countermeasure to the nitrogen mustard mechlorethamine. Lulla A; Reznik S; Trombetta L; Billack B J Appl Toxicol; 2014 Dec; 34(12):1373-8. PubMed ID: 24347431 [TBL] [Abstract][Full Text] [Related]
15. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. Dachir S; Fishbeine E; Meshulam Y; Sahar R; Chapman S; Amir A; Kadar T J Appl Toxicol; 2004; 24(2):107-13. PubMed ID: 15052605 [TBL] [Abstract][Full Text] [Related]
16. Response of normal human keratinocytes to sulfur mustard: cytokine release. Arroyo CM; Schafer RJ; Kurt EM; Broomfield CA; Carmichael AJ J Appl Toxicol; 2000 Dec; 20 Suppl 1():S63-72. PubMed ID: 11428645 [TBL] [Abstract][Full Text] [Related]